Louise Cominato
Research Subjects
Research Interests
Louise Cominato has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
Durval Damiani
Department of Pediatric Endocrinology, Institute for Children and Adolescents, Hospital das Clínicas, Faculty of Medicine, Brazil
7 shared publicationsLeandra Steinmetz
Instituto da Criança, São Paulo, Brazil
4 shared publications- Marina Ybarra
Research Center of Sainte Justine University Hospital, Université de Montréal, Montreal, Quebec, Canada
3 shared publications Ruth Rocha Franco
Instituto da Criança, São Paulo, Brazil
3 shared publications- Ruth Rocha Franco
Instituto da Criança do Hospital das Clínicas da FMUSP, São Paulo/SP, Brasil
3 shared publications - Durval Damiani
Universidade de São Paulo, Brasil
2 shared publications
Latest Publications
- Open Access
- 19 September 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1663499
12-month outcomes of GLP - 1 in severe pediatric obesity: real-world data
Background: Real-world data on liraglutide for pediatric obesity is limited, especially in public healthcare systems of low- and middle-income countries.Objective: To evaluate the real-world effectiveness and safety of liraglutide in managing severe obesity among children and adolescents with severe obesity treated at a public quaternary hospital in Brazil.Methods: This cohort study included patients aged 6–17.9 years with BMI Z-score (Z-BMI) ≥+3, treated with liraglutide (up to 3.0 mg/day) and lifestyle intervention. Outcomes included changes in BMI, Z-BMI, weight, WHtR, metabolic markers, and adverse events over 3 months, 6 months and 12 months.Results: Of 74 patients, 55 completed 6 months and 22 completed 12 months. In patients aged 6–12 years (n=23), median Z-BMI decreased from +3.90 (3.4 - 5.1) to +3.06 (2.7 - 3.7) (p < 0.0001), and WHtR from 0.70 (0.66 - 0.73) to 0.64 (0.60 - 0.68) (p < 0.0001); 82.6% achieved ≥5% BMI reduction and 47.8% ≥10% BMI reduction. In adolescents aged ≥12 years (n=32), Z-BMI declined from +3.77 (3.02 - 4.66) to +3.48 (2.64 - 4.34) (p < 0.0001), and WHtR from 0.74 (0.62 - 0.80) to 0.67 (0.58 - 0.76) (p < 0.0001); 73.9% achieved ≥5% and 43.5% ≥10% BMI reduction. Improvements were also observed in LDL cholesterol, HbA1c, and HOMA-IR. Adverse events were mild and transient.Conclusion: Liraglutide was effective and safe in reducing adiposity and improving metabolic health in children and adolescents with severe obesity in a real-world setting.
- 19 September 2025
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 16, 1663499
Open Access12-month outcomes of GLP - 1 in severe pediatric obesity: real-world data
Background: Real-world data on liraglutide for pediatric obesity is limited, especially in public healthcare systems of low- and middle-income countries.Objective: To evaluate the real-world effectiveness and safety of liraglutide in managing severe obesity among children and adolescents with severe obesity treated at a public quaternary hospital in Brazil.Methods: This cohort study included patients aged 6–17.9 years with BMI Z-score (Z-BMI) ≥+3, treated with liraglutide (up to 3.0 mg/day) and lifestyle intervention. Outcomes included changes in BMI, Z-BMI, weight, WHtR, metabolic markers, and adverse events over 3 months, 6 months and 12 months.Results: Of 74 patients, 55 completed 6 months and 22 completed 12 months. In patients aged 6–12 years (n=23), median Z-BMI decreased from +3.90 (3.4 - 5.1) to +3.06 (2.7 - 3.7) (p < 0.0001), and WHtR from 0.70 (0.66 - 0.73) to 0.64 (0.60 - 0.68) (p < 0.0001); 82.6% achieved ≥5% BMI reduction and 47.8% ≥10% BMI reduction. In adolescents aged ≥12 years (n=32), Z-BMI declined from +3.77 (3.02 - 4.66) to +3.48 (2.64 - 4.34) (p < 0.0001), and WHtR from 0.74 (0.62 - 0.80) to 0.67 (0.58 - 0.76) (p < 0.0001); 73.9% achieved ≥5% and 43.5% ≥10% BMI reduction. Improvements were also observed in LDL cholesterol, HbA1c, and HOMA-IR. Adverse events were mild and transient.Conclusion: Liraglutide was effective and safe in reducing adiposity and improving metabolic health in children and adolescents with severe obesity in a real-world setting.
- Open Access
Poor Sleep quality and health-related quality of life impact in adolescents with and without chronic immunosuppressive conditions during COVID-19 quarantine
To assess the possible factors that influence sleep quality in adolescents with and without chronic immunosuppressive conditions quarantined during the coronavirus disease 2019 (COVID-19) pandemic. This cross-sectional study included 305 adolescents with chronic immunocompromised conditions and 82 healthy adolescents. Online surveys were completed, which included questions on socio-demographic data and self-rated healthcare routine during COVID-19 quarantine and the following validated questionnaires: the Pittsburgh Sleep Quality Index (PSQI), Pediatric Quality of Life Inventory 4.0 (PedsQL4.0), and Pediatric Outcome Data Collection Instrument (PODCI). The median current age [14 (10-18) vs. 15 (10-18) years, p=0.847] and frequency of female sex (62% vs. 58%, p=0.571) were similar in adolescents with chronic conditions compared with healthy adolescents. The frequency of poor sleep quality was similar in both groups (38% vs. 48%, p=0.118). Logistic regression analysis, including both healthy adolescents and adolescents with chronic conditions (n=387), demonstrated that self-reported increase in screen time (odds ratio [OR] 3.0; 95% confidence interval [CI] 1.3-6.8; p=0.008) and intrafamilial violence report (OR 2.1; 95% CI 1.2-3.5; p=0.008) were independently associated with poor sleep quality in these adolescents. However, the PODCI global function score was associated with a lower OR for poor sleep quality (OR 0.97; 95% CI 0.94-0.99; p=0.001). Further logistic regression, including only adolescents with chronic conditions (n=305), demonstrated that self-reported increase in screen time (OR 3.1; 95% CI 1.4-6.8; p=0.006) and intrafamilial violence report (OR 2.0; 95% CI 1.2-3.4; p=0.011) remained independently associated with poor quality of sleep, whereas a lower PODCI global function score was associated with a lower OR for sleep quality (OR 0.96; 95% CI 0.94-0.98; p<0.001). Self-reported increases in screen time and intrafamilial violence report impacted sleep quality in both healthy adolescents and those with chronic conditions. Decreased health-related quality of life was observed in adolescents with poor sleep quality.
Open AccessPoor Sleep quality and health-related quality of life impact in adolescents with and without chronic immunosuppressive conditions during COVID-19 quarantine
To assess the possible factors that influence sleep quality in adolescents with and without chronic immunosuppressive conditions quarantined during the coronavirus disease 2019 (COVID-19) pandemic. This cross-sectional study included 305 adolescents with chronic immunocompromised conditions and 82 healthy adolescents. Online surveys were completed, which included questions on socio-demographic data and self-rated healthcare routine during COVID-19 quarantine and the following validated questionnaires: the Pittsburgh Sleep Quality Index (PSQI), Pediatric Quality of Life Inventory 4.0 (PedsQL4.0), and Pediatric Outcome Data Collection Instrument (PODCI). The median current age [14 (10-18) vs. 15 (10-18) years, p=0.847] and frequency of female sex (62% vs. 58%, p=0.571) were similar in adolescents with chronic conditions compared with healthy adolescents. The frequency of poor sleep quality was similar in both groups (38% vs. 48%, p=0.118). Logistic regression analysis, including both healthy adolescents and adolescents with chronic conditions (n=387), demonstrated that self-reported increase in screen time (odds ratio [OR] 3.0; 95% confidence interval [CI] 1.3-6.8; p=0.008) and intrafamilial violence report (OR 2.1; 95% CI 1.2-3.5; p=0.008) were independently associated with poor sleep quality in these adolescents. However, the PODCI global function score was associated with a lower OR for poor sleep quality (OR 0.97; 95% CI 0.94-0.99; p=0.001). Further logistic regression, including only adolescents with chronic conditions (n=305), demonstrated that self-reported increase in screen time (OR 3.1; 95% CI 1.4-6.8; p=0.006) and intrafamilial violence report (OR 2.0; 95% CI 1.2-3.4; p=0.011) remained independently associated with poor quality of sleep, whereas a lower PODCI global function score was associated with a lower OR for sleep quality (OR 0.96; 95% CI 0.94-0.98; p<0.001). Self-reported increases in screen time and intrafamilial violence report impacted sleep quality in both healthy adolescents and those with chronic conditions. Decreased health-related quality of life was observed in adolescents with poor sleep quality.
- 5 October 2021
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 94 (11-12) , 410-415
Obesity as a Thrombogenic and Cardiovascular Risk Factor in Children
Background/Aims: Obesity leads to increased risk of thromboembolic events in adults, but few studies have addressed the relationship between obesity and thrombogenic risk during childhood. The aim of this study was to evaluate the prothrombotic state of obese children in comparison with healthy children. Methods: Thrombin generation, fibrinogen, and D-dimer levels, along with metabolic parameters, were measured in 72 prepubertal children, of which 47 were obese and 25 eutrophic. Results: A significant increase in thrombin generation, fibrinogen, and dyslipidemia was found among obese patients. Conclusion: A prothrombotic state develops in childhood obesity during the prepubertal phase.
- 5 October 2021
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 94 (11-12) , 410-415
Obesity as a Thrombogenic and Cardiovascular Risk Factor in Children
Background/Aims: Obesity leads to increased risk of thromboembolic events in adults, but few studies have addressed the relationship between obesity and thrombogenic risk during childhood. The aim of this study was to evaluate the prothrombotic state of obese children in comparison with healthy children. Methods: Thrombin generation, fibrinogen, and D-dimer levels, along with metabolic parameters, were measured in 72 prepubertal children, of which 47 were obese and 25 eutrophic. Results: A significant increase in thrombin generation, fibrinogen, and dyslipidemia was found among obese patients. Conclusion: A prothrombotic state develops in childhood obesity during the prepubertal phase.
- Open Access
- 1 September 2021
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 65 (5) , 527-536
Adolescent obesity treatments: news, views, and evidence
Obesity is a complex and multifactorial disease that is influenced by physiological, environmental, socioeconomic, and genetic factors. In recent decades, this serious disease has impacted a large number of adolescents as a result of lifestyle factors. A lack of exercise and the consumption of excessive calories from an inadequate diet are the main contributors to adolescent obesity. However, genetic and hormonal factors might also play a role. The short- and long-term consequences of this disease include chronic issues such as type 2 diabetes and cardiovascular disorders and an increase in early mortality rates. Although it is a serious disease, obesity in adolescents can be controlled with diet and exercise. When these lifestyle changes do not obtain the expected results, we can intensify the treatment by adding medication to the practice of diet and exercise. Additionally, for more severe cases, bariatric surgery can be an option. The purpose of this review is to clarify the current epidemiology, risks, and comorbidities and discuss news about the main treatments and the necessary improvements in this context. Arch Endocrinol Metab. 2021;65(5):527-36
- 1 September 2021
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 65 (5) , 527-536
Open AccessAdolescent obesity treatments: news, views, and evidence
Obesity is a complex and multifactorial disease that is influenced by physiological, environmental, socioeconomic, and genetic factors. In recent decades, this serious disease has impacted a large number of adolescents as a result of lifestyle factors. A lack of exercise and the consumption of excessive calories from an inadequate diet are the main contributors to adolescent obesity. However, genetic and hormonal factors might also play a role. The short- and long-term consequences of this disease include chronic issues such as type 2 diabetes and cardiovascular disorders and an increase in early mortality rates. Although it is a serious disease, obesity in adolescents can be controlled with diet and exercise. When these lifestyle changes do not obtain the expected results, we can intensify the treatment by adding medication to the practice of diet and exercise. Additionally, for more severe cases, bariatric surgery can be an option. The purpose of this review is to clarify the current epidemiology, risks, and comorbidities and discuss news about the main treatments and the necessary improvements in this context. Arch Endocrinol Metab. 2021;65(5):527-36
- Open Access
Therapeutic Education Program for Children and Adolescents with chronic diseases - Letter to the Editor
To the Editor, Health care often places patient assistance centered on prescriptive acts that frequently result in procedures effective only in the biomedical dimensions without considering the social, environmental, and circumstantial factors that affect the evolution of the health status of a person with a chronic disease (). […] Therapeutic Education Program for Children and Adolescents with chronic diseases – Letter to the Editor To the Editor, Health care often places patient assistance centered on prescriptive acts that frequently result in procedures effective only in the biomedical dimensions without considering the social, environmental, and circumstantial factors that affect the evolution of the health status of a person with a chronic disease (). […] Therapeutic Education Program for Children and Adolescents with chronic diseases – Letter to the Editor
Open AccessTherapeutic Education Program for Children and Adolescents with chronic diseases - Letter to the Editor
To the Editor, Health care often places patient assistance centered on prescriptive acts that frequently result in procedures effective only in the biomedical dimensions without considering the social, environmental, and circumstantial factors that affect the evolution of the health status of a person with a chronic disease (). […] Therapeutic Education Program for Children and Adolescents with chronic diseases – Letter to the Editor To the Editor, Health care often places patient assistance centered on prescriptive acts that frequently result in procedures effective only in the biomedical dimensions without considering the social, environmental, and circumstantial factors that affect the evolution of the health status of a person with a chronic disease (). […] Therapeutic Education Program for Children and Adolescents with chronic diseases – Letter to the Editor
- Open Access
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Revista Paulista de Pediatria
- Vol. 38, e2018239
BARIATRIC SURGERY AS A TREATMENT FOR IDIOPATHIC INTRACRANIAL HYPERTENSION IN A MALE ADOLESCENT: CASE REPORT
Objective: To describe a case of a male adolescent with symptomatic idiopathic intracranial hypertension (IIH) associated with obesity treated with bariatric surgery. Case description: A 16-year-and-6-month-old severely obese boy [weight: 133.6 kg; height: 1.74 m (Z score: +0.14); BMI: 44.1 kg/m2 (Z score: +4.4)], Tanner pubertal stage 5, presented biparietal, high-intensity, and pulsatile headaches, about five times per week, associated with nocturnal awakenings, and partial improvement with common analgesics, for three months. Ophthalmologic evaluation evidenced bilateral papilledema. Cranial computed tomography revealed no mass or anatomic abnormalities. Lumbar puncture showed increased intracranial pressure of 40 cmH2O (reference value: <28 cmH2O) with a normal content. After being diagnosed with IIH, the patient was started on acetazolamide. However, after three months, he was still symptomatic. He was diagnosed with obesity due to excess energy intake and, as he had failed to lose weight after a conventional clinical treatment, bariatric surgery was indicated. The patient (at 16 years and nine months) underwent an uncomplicated laparoscopic sleeve gastrectomy. Ophthalmologic evaluation, performed five months after surgery, revealed normal visual acuity in both eyes and improvement of bilateral papilledema. Follow-up at 18 months showed a 67.5% loss of excess weight (weight: 94.5 kg and BMI: 31.2 kg/m2) and complete resolution of IIH symptoms. Comments: IIH is characterized by increased intracranial pressure with no evidence of deformity or obstruction of the ventricular system on neuroimaging. It has been associated with obesity. Bariatric surgery may be a valid alternative approach for morbidly obese adolescent patients with refractory symptoms.
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Revista Paulista de Pediatria
- Vol. 38, e2018239
Open AccessBARIATRIC SURGERY AS A TREATMENT FOR IDIOPATHIC INTRACRANIAL HYPERTENSION IN A MALE ADOLESCENT: CASE REPORT
Objective: To describe a case of a male adolescent with symptomatic idiopathic intracranial hypertension (IIH) associated with obesity treated with bariatric surgery. Case description: A 16-year-and-6-month-old severely obese boy [weight: 133.6 kg; height: 1.74 m (Z score: +0.14); BMI: 44.1 kg/m2 (Z score: +4.4)], Tanner pubertal stage 5, presented biparietal, high-intensity, and pulsatile headaches, about five times per week, associated with nocturnal awakenings, and partial improvement with common analgesics, for three months. Ophthalmologic evaluation evidenced bilateral papilledema. Cranial computed tomography revealed no mass or anatomic abnormalities. Lumbar puncture showed increased intracranial pressure of 40 cmH2O (reference value: <28 cmH2O) with a normal content. After being diagnosed with IIH, the patient was started on acetazolamide. However, after three months, he was still symptomatic. He was diagnosed with obesity due to excess energy intake and, as he had failed to lose weight after a conventional clinical treatment, bariatric surgery was indicated. The patient (at 16 years and nine months) underwent an uncomplicated laparoscopic sleeve gastrectomy. Ophthalmologic evaluation, performed five months after surgery, revealed normal visual acuity in both eyes and improvement of bilateral papilledema. Follow-up at 18 months showed a 67.5% loss of excess weight (weight: 94.5 kg and BMI: 31.2 kg/m2) and complete resolution of IIH symptoms. Comments: IIH is characterized by increased intracranial pressure with no evidence of deformity or obstruction of the ventricular system on neuroimaging. It has been associated with obesity. Bariatric surgery may be a valid alternative approach for morbidly obese adolescent patients with refractory symptoms.
- 8 May 2018
- Published by Springer Nature in Current Obesity Reports
- Vol. 7 (2) , 97-104
Obesity Prevention: Strategies and Challenges in Latin America
The purpose of this study is to present changes of policies and norms aimed to reduce obesity levels that have been adopted in some Latin American countries.
- 8 May 2018
- Published by Springer Nature in Current Obesity Reports
- Vol. 7 (2) , 97-104
Obesity Prevention: Strategies and Challenges in Latin America
The purpose of this study is to present changes of policies and norms aimed to reduce obesity levels that have been adopted in some Latin American countries.
- Open Access
Review of a three-year study on the dental care of onco-hematological pediatric patients
The aim of this study was to provide an updated review of dental procedures undertaken at the dental unit of the Onco-hematology service of the Instituto da Criança at the Hospital das Clínicas, Faculdade de Medicina, Universidade de São ...
Open AccessReview of a three-year study on the dental care of onco-hematological pediatric patients
The aim of this study was to provide an updated review of dental procedures undertaken at the dental unit of the Onco-hematology service of the Instituto da Criança at the Hospital das Clínicas, Faculdade de Medicina, Universidade de São ...
- Open Access
- 1 December 2017
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 61 (6) , 608-613
Laparoscopic sleeve gastrectomy in severely obese adolescents: effects on metabolic profile
Keywords Bariatric surgery; sleeve gastrectomy; obesity; adolescent
- 1 December 2017
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 61 (6) , 608-613
Open AccessLaparoscopic sleeve gastrectomy in severely obese adolescents: effects on metabolic profile
Keywords Bariatric surgery; sleeve gastrectomy; obesity; adolescent
- 29 July 2017
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 34 (1) , 45-48
Polycystic Ovary Syndrome among Obese Adolescents
Background and aims: In adolescence and obesity, the pathophysiology of polycystic ovary syndrome (PCOS) is very difficult to distinguish. We aimed to assess the diagnosis of PCOS in the population of obese adolescent. Methods: Cross-sectional study. Setting: Pediatric Endocrinology Weight and Management Clinic from Children's Institute, São Paulo, Brazil. Participants: Forty-nine post-menarcheal obese adolescents with mean age of 14.7 years. Interventions: Anthropometric assessment and review of medical records were done. Clinical and laboratory hyperandrogenism were quantified using Ferriman–Gallwey index and androgenic dosages, respectively. Ovarian morphology was evaluated through suprapubic ultrasonography. Results: By the 2015 Witchel et al. guideline for PCOS in adolescence, 18.4% were diagnosed as having PCOS. When assessed by Rotterdam, Androgen Excess and PCOS Society, and American National Institute of Health criteria's, 26.4%, 22.4%, and 20.4% had PCOS, respectively. Irregular menstrual cycles were found in 65.3% of patients. Clinical hyperandrogenism was observed in 16.3% of girls and 18.4% had elevated serum androgen values. Suprapubic ultrasonography revealed enlarged ovaries in 18.4% of the adolescents. Conclusions: PCOS in all-comers obese adolescents from a Weight and Management Clinic in a quaternary hospital is more frequent when compared to adult women showed in the literature.
- 29 July 2017
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 34 (1) , 45-48
Polycystic Ovary Syndrome among Obese Adolescents
Background and aims: In adolescence and obesity, the pathophysiology of polycystic ovary syndrome (PCOS) is very difficult to distinguish. We aimed to assess the diagnosis of PCOS in the population of obese adolescent. Methods: Cross-sectional study. Setting: Pediatric Endocrinology Weight and Management Clinic from Children's Institute, São Paulo, Brazil. Participants: Forty-nine post-menarcheal obese adolescents with mean age of 14.7 years. Interventions: Anthropometric assessment and review of medical records were done. Clinical and laboratory hyperandrogenism were quantified using Ferriman–Gallwey index and androgenic dosages, respectively. Ovarian morphology was evaluated through suprapubic ultrasonography. Results: By the 2015 Witchel et al. guideline for PCOS in adolescence, 18.4% were diagnosed as having PCOS. When assessed by Rotterdam, Androgen Excess and PCOS Society, and American National Institute of Health criteria's, 26.4%, 22.4%, and 20.4% had PCOS, respectively. Irregular menstrual cycles were found in 65.3% of patients. Clinical hyperandrogenism was observed in 16.3% of girls and 18.4% had elevated serum androgen values. Suprapubic ultrasonography revealed enlarged ovaries in 18.4% of the adolescents. Conclusions: PCOS in all-comers obese adolescents from a Weight and Management Clinic in a quaternary hospital is more frequent when compared to adult women showed in the literature.